JOHNSON & JOHNSON, BAYER HIT WITH $28 MILLION XARELTO VERDICT
Sales in 2016 for the extremely popular blood thinner Xarelto reached over $3.2 Billion. But in their hustle to make some money, Xarelto manufacturer Johnson & Johnson may have cut a few corners in letting their patients know the various side effects of their drug. One such risk has to do with internal and external bleeding. In […]

